CDC vs. AVGX
CDC (VictoryShares US EQ Income Enhanced Volatility Wtd ETF) and AVGX (Defiance Daily Target 2X Long AVGO ETF) are both exchange-traded funds - CDC is a Large Cap Value Equities fund tracking the Nasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index, while AVGX is a Leveraged Equities fund actively managed by Defiance. CDC is passively managed, while AVGX is actively managed. Over the past year, CDC returned 18.16% vs 156.34% for AVGX. At a 0.03 correlation, their price movements are largely independent. CDC charges 0.37%/yr vs 1.29%/yr for AVGX.
Performance
CDC vs. AVGX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CDC achieves a 10.57% return, which is significantly lower than AVGX's 69.89% return.
CDC
- 1D
- -0.57%
- 1M
- -0.39%
- YTD
- 10.57%
- 6M
- 10.29%
- 1Y
- 18.16%
- 3Y*
- 11.97%
- 5Y*
- 5.08%
- 10Y*
- 10.03%
AVGX
- 1D
- -0.83%
- 1M
- 29.49%
- YTD
- 69.89%
- 6M
- 35.83%
- 1Y
- 156.34%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CDC vs. AVGX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | 10.57% | 8.96% | 1.41% |
AVGX Defiance Daily Target 2X Long AVGO ETF | 69.89% | 46.98% | 69.92% |
Correlation
The correlation between CDC and AVGX is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.08 |
Correlation (All Time) Calculated using the full available price history since Aug 23, 2024 | 0.03 |
The correlation between CDC and AVGX shifts across timeframes, from -0.08 (1 year) to 0.03 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CDC vs. AVGX — Risk / Return Rank
CDC
AVGX
CDC vs. AVGX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) and Defiance Daily Target 2X Long AVGO ETF (AVGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CDC | AVGX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.03 | ||
| Sortino ratioReturn per unit of downside risk | +0.33 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.31 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 3.22 | 2.91 | +0.31 |
| Martin ratioReturn relative to average drawdown | 11.37 | 6.49 | +4.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CDC | AVGX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.87 | 1.83 | +0.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.41 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.76 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.74 | 1.21 | -0.47 |
Drawdowns
CDC vs. AVGX - Drawdown Comparison
The maximum CDC drawdown since its inception was -21.37%, smaller than the maximum AVGX drawdown of -70.97%. Use the drawdown chart below to compare losses from any high point for CDC and AVGX.
Loading charts...
Drawdown Indicators
| CDC | AVGX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -21.37% | -70.97% | +49.60% |
Max Drawdown (1Y)Largest decline over 1 year | -5.67% | -54.09% | +48.42% |
Max Drawdown (3Y)Largest decline over 3 years | -12.70% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -21.37% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -21.37% | — | — |
Current DrawdownCurrent decline from peak | -2.20% | -0.83% | -1.37% |
Average DrawdownAverage peak-to-trough decline | -5.09% | -22.71% | +17.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.60% | 24.20% | -22.60% |
Volatility
CDC vs. AVGX - Volatility Comparison
The current volatility for VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) is 2.66%, while Defiance Daily Target 2X Long AVGO ETF (AVGX) has a volatility of 23.50%. This indicates that CDC experiences smaller price fluctuations and is considered to be less risky than AVGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CDC | AVGX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 2.66% | 23.50% | -20.84% |
Volatility (6M)Calculated over the trailing 6-month period | 6.84% | 61.90% | -55.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 9.77% | 85.97% | -76.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 12.54% | 104.65% | -92.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 13.21% | 104.65% | -91.44% |
CDC vs. AVGX - Expense Ratio Comparison
CDC has a 0.37% expense ratio, which is lower than AVGX's 1.29% expense ratio.
Dividends
CDC vs. AVGX - Dividend Comparison
CDC's dividend yield for the trailing twelve months is around 3.18%, more than AVGX's 0.97% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVGX Defiance Daily Target 2X Long AVGO ETF | 0.97% | 1.65% | 0.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | 3.18% | 3.36% | 3.32% | 4.24% | 3.48% | 2.65% | 2.48% | 3.04% | 3.37% | 2.81% | 2.99% | 3.17% |
Frequently Asked Questions
CDC and AVGX have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVGX has higher volatility (23.50%) compared to CDC (2.66%). In terms of maximum drawdown, CDC dropped -21.37% vs AVGX's -70.97%.
On 1-year performance, AVGX leads with 156.34% vs 18.16% for CDC. On fees, CDC is cheaper at 0.37% per year. On volatility, CDC has been the lower-risk option at 2.66%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, AVGX has performed better with a 156.34% return vs 18.16%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CDC is cheaper with a 0.37% expense ratio, compared with 1.29% for AVGX.
CDC has the higher dividend yield at 3.18%, compared with 0.97% for AVGX.
CDC is categorized as Large Cap Value Equities, while AVGX is Leveraged Equities. They also come from different issuers: Crestview and Defiance. Their fees differ too: 0.37% for CDC and 1.29% for AVGX.
CDC currently has the higher Sharpe Ratio (1.87 vs 1.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CDC and AVGX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer